NAD+ (Nicotinamide Adenine Dinucleotide) occupies a unique position in longevity and cellular biology research. Unlike most research compounds that enter the literature from a specific discovery, NAD+ has been known to biochemists since 1906 — yet it has experienced a significant resurgence of scientific interest over the past two decades, driven by the discovery of its role as a critical substrate for enzymes involved in ageing, DNA repair, and metabolic regulation.
This article covers what NAD+ is, the mechanisms documented in the research, what the published studies show, and what researchers working with it need to know.
01 — What Is NAD+?
NAD+ is a dinucleotide coenzyme found in every living cell. It consists of two nucleotides — adenine and nicotinamide — joined by a phosphate bridge. It exists in two primary forms: the oxidised form (NAD+) and the reduced form (NADH), and the ratio between these forms reflects the metabolic state of the cell.
Its role as a redox coenzyme — shuttling electrons between molecules in metabolic pathways — has been understood since the early twentieth century. What renewed scientific interest is a separate function: NAD+ serves as a substrate (consumed in the reaction) for a class of regulatory enzymes, most notably sirtuins and PARPs, that are central to ageing research.
NAD+ levels in mammalian tissue decline measurably with age. This age-dependent decline has been documented in multiple species and tissue types, and is considered a key factor in the metabolic and functional changes associated with ageing at the cellular level.
02 — Proposed Mechanisms
Sirtuin Activation
Sirtuins (SIRT1–SIRT7) are a family of NAD+-dependent deacylase enzymes involved in regulating a wide range of cellular processes: gene expression, DNA repair, mitochondrial biogenesis, inflammation, and circadian rhythm. They are often described as metabolic sensors — their activity is directly coupled to NAD+ availability, meaning they are more active when NAD+ levels are high.
Research has shown that sirtuins regulate several processes implicated in cellular ageing, including:
SIRT1 — deacetylation of p53, NF-κB, and PGC-1α; involved in stress response and mitochondrial regulation
SIRT3 — mitochondrial protein deacetylation; linked to oxidative stress management
SIRT6 — DNA repair and telomere maintenance
The dependency of these pathways on NAD+ availability is the primary mechanistic basis for the research interest in NAD+ as a longevity-relevant compound.
PARP Activation and DNA Repair
Poly(ADP-ribose) polymerases (PARPs) are another major class of NAD+-consuming enzymes. PARPs detect DNA strand breaks and initiate the repair response by synthesising poly(ADP-ribose) chains — consuming NAD+ in the process. PARP1, the most abundant member of the family, is responsible for the majority of this NAD+ consumption following DNA damage.
Research has shown that excessive PARP activation — driven by accumulated DNA damage with age — is a significant contributor to NAD+ depletion in aged tissue. This creates a potential cycle: lower NAD+ reduces sirtuin activity, which impairs some DNA repair pathways, which leads to more damage and more PARP activation, further depleting NAD+.
Mitochondrial Function
NAD+ is essential to mitochondrial oxidative phosphorylation — the process by which cells generate ATP. Both NAD+ (as an electron acceptor in the citric acid cycle) and NADH (as an electron donor in the electron transport chain) are required for this process to function. Research examining mitochondrial decline in aged tissue has consistently documented reduced NAD+/NADH ratios as a feature of this decline.
CD38 and NAD+ Degradation
CD38 is an enzyme that degrades NAD+ and is expressed on immune cells and other tissues. Research has shown that CD38 expression increases with age and with chronic inflammation — and that this increase is a significant driver of age-related NAD+ decline, independent of reduced biosynthesis. Several studies have examined CD38 inhibition as a means of preserving NAD+ levels in animal models.
03 — What the Published Studies Show
Ageing and Lifespan in Animal Models
Research using NAD+ precursor supplementation in animal models has shown consistent improvements in metabolic markers associated with ageing: improved insulin sensitivity, increased mitochondrial content, enhanced physical performance in aged subjects, and extended lifespan in several model organisms. Studies by Yoshino, Guarente, and others established much of this foundational evidence across the 2010s.
DNA Repair
Research has demonstrated that restoring NAD+ levels in aged cells improves the efficiency of DNA repair pathways — particularly base excision repair and double-strand break repair mediated via SIRT1 and PARP1. A 2013 study by Gomes et al. published in Cell identified the mitochondrial-nuclear communication pathway disrupted by NAD+ decline and showed that NAD+ restoration could reverse mitochondrial dysfunction in aged mice.
Neurological Research
NAD+ has been examined in multiple neurological research contexts. Animal studies have shown neuroprotective effects in models of neurodegeneration, with proposed mechanisms involving both sirtuin-mediated stress responses and improved mitochondrial function in neurons. This is an active area of the literature with growing published output.
Human Studies
Unlike most research peptides, NAD+ has progressed to human clinical investigation. Studies examining intravenous and oral NAD+ precursor (NMN and NR) supplementation in human subjects have been published, showing dose-dependent increases in blood NAD+ levels. The downstream biological effects of these increases in humans remain under active investigation, with larger trials ongoing.
04 — NAD+ vs NAD+ Precursors
It is worth distinguishing between NAD+ itself and its biosynthetic precursors — primarily NMN (Nicotinamide Mononucleotide) and NR (Nicotinamide Riboside). Most oral supplementation research uses precursors because NAD+ itself is poorly absorbed intact via the gut. For intravenous research applications, NAD+ can be used directly.
The distinction matters for research design: precursor studies measure indirect effects via biosynthetic conversion, while direct NAD+ administration bypasses this step.
05 — What Is Not Yet Established
Optimal research parameters for direct NAD+ administration are not standardised across applications
Long-term effects of sustained elevated NAD+ levels are not fully characterised, including potential effects on PARP-mediated DNA repair signalling
Cancer research context — sirtuins have complex roles in both tumour suppression and progression; the implications of NAD+ elevation for cancer biology research require careful consideration in protocol design
Translation from animal models — significant metabolic differences between rodents and humans mean that animal findings on NAD+ do not translate directly to human predictions
06 — Research Formats
NAD+ is available as a lyophilised powder for research applications. It requires reconstitution with bacteriostatic water before use in any laboratory research protocol. Full reconstitution guide →
Unreconstituted vials should be stored refrigerated and protected from light. Reconstituted solutions should be kept refrigerated and used within 28–30 days.
